{
  "patent_number": "US 12734139",
  "country": "US",
  "title": "Ensifentrine Drug for Reducing COPD Flare-Ups",
  "original_title": "Ensifentrine for decreasing the frequency/severity of COPD exacerbations",
  "summary": "This patent describes using the drug ensifentrine to reduce how often and how severe flare-ups of chronic obstructive pulmonary disease (COPD) are in patients.",
  "what_it_does": "This patent focuses on using the compound ensifentrine, or a similar salt form of it, to help patients with chronic obstructive pulmonary disease (COPD). Specifically, the invention aims to decrease the frequency and/or severity of COPD exacerbations. An exacerbation is a sudden worsening of COPD symptoms, like increased shortness of breath or coughing. For example, a patient with COPD who frequently experiences severe breathing crises could be given ensifentrine to make these events happen less often or be less intense when they do occur.",
  "what_it_does_not_cover": [
    "Does not cover using ensifentrine for treating other diseases not related to COPD.",
    "Does not cover using other drugs or compounds to treat COPD exacerbations.",
    "Does not cover preventing the initial development of COPD in a healthy individual.",
    "Does not cover ensifentrine for general, non-exacerbation related COPD symptom management, but specifically targets exacerbations.",
    "Does not cover different chemical structures or derivatives of ensifentrine that are not pharmaceutically acceptable salts."
  ],
  "filed": "2024-01-26",
  "granted": "2026-09-15",
  "expires": null,
  "status": "active",
  "holder": null,
  "holder_url": null,
  "inventors": [],
  "times_cited": 0,
  "tags": [
    "pharmaceutical",
    "biotech"
  ],
  "abstract": "The present invention relates to a compound for use in a method for decreasing the frequency and/or severity of chronic obstructive pulmonary disease (COPD) exacerbations in a patient suffering from COPD, wherein the compound is ensifentrine or a pharmaceutically acceptable salt thereof. The present invention also relates to a compound for use in a method for treating chronic obstructive pulmonary disease (COPD) in a patient, wherein: the compound is ensifentrine or a pharmaceutically acceptable salt thereof; and the patient is susceptible to COPD exacerbations.",
  "url": "https://patentbrief.org/patent/us/12734139/ensifentrine-for-decreasing-the-frequencyseverity-of-copd-exacerbations",
  "markdown_url": "https://patentbrief.org/patent/us/12734139/ensifentrine-for-decreasing-the-frequencyseverity-of-copd-exacerbations/md",
  "google_patents_url": "https://patents.google.com/patent/US12734139",
  "relatedPatents": []
}